Dali Pharmaceuticalco.,Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 132.33 million compared to CNY 171.47 million a year ago. Revenue was CNY 132.34 million compared to CNY 171.49 million a year ago.

Net loss was CNY 17.7 million compared to CNY 41.89 million a year ago. Basic loss per share from continuing operations was CNY 0.08 compared to CNY 0.19 a year ago. Diluted loss per share from continuing operations was CNY 0.08 compared to CNY 0.19 a year ago.